On the stock market since 2021, it operates in the world of health and science. It has 313 employees. Now — the numbers.
This is an established company with proven profits.
Average growth of 28% a year over the last 4 years. Every year shown ended in profit.
If every debt were paid off today, $613.3M would still be left in the vault — a solid cushion for hard times.
An investor who bought at the very peak is down 89% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
There is $614.9M in the vault; even if every debt were paid off, $613.3M would remain.
Nothing in the current numbers stands out as a clear risk. Still, no stock is ever risk-free.
On our five-subject report card, SUSRF sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: SUSRF is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.